SL
Scott L Burrows
DELAYED 1 MONTH
Chief Financial Officer
Spyre Therapeutics, Inc.
Filings
3
Companies
1
Latest
Jun 1, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
66
SYRECLUSTER 3
Spyre Therapeutics, Inc.
Scott L Burrows
Chief Financial Officer
Sale
$532.9K
7,500 sh
Jun 4 1:30 AM
Jun 1, 2026
—
Spyre Therapeutics, Inc.
Scott L Burrows
Chief Financial Officer
Option Exercise
$108.8K
7,500 sh
Jun 4 1:30 AM
Jun 1, 2026
70
SYRECLUSTER 3
Spyre Therapeutics, Inc.
Scott L Burrows
Chief Financial Officer
Sale
$892.1K
12,500 sh
May 2 1:35 AM
May 1, 2026
—
Spyre Therapeutics, Inc.
Scott L Burrows
Chief Financial Officer
Option Exercise
$181.3K
12,500 sh
May 2 1:35 AM
May 1, 2026
58
SYRECLUSTER 2
Spyre Therapeutics, Inc.
Scott L Burrows
Chief Financial Officer
Sale
$101.6K
2,500 sh
Mar 4 2:32 AM
Mar 3, 2026
—
Spyre Therapeutics, Inc.
Scott L Burrows
Chief Financial Officer
Option Exercise
$36.3K
2,500 sh
Mar 4 2:32 AM
Mar 3, 2026